InsiderTrades.com logo
Kristen Yen net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Kristen Yen Biography and Net Worth

Senior Vice President, Clinical Operations of Soleno Therapeutics

Ms. Yen has over 20 years of clinical research experience in the pharmaceutical and medical de vice industries. She joined the Company 2006, and currently serves as the Senior Vice President of Clinical Operations. Prior to joining the Company, she managed multiple U.S. and global clinical studies in oncology and held various positions of increasing responsibility at Titan Pharmaceuticals. She began her career in the industry as a clinical employee at PRA International. She has served as a team member and managed clinical studies in neonatology, neurology, pulmonary/allergy, cardiovascular disease, endocrine/metabolic disease, and oncology. She earned a Bachelor of Science degree in mathematics from the University of California, Davis, and a Master of Science degree in cell, molecular and neurosciences from the University of Hawaii, Manoa.

What is Kristen Yen's net worth?

The estimated net worth of Kristen Yen is at least $4.04 million as of January 3rd, 2025. Ms. Yen owns 76,605 shares of Soleno Therapeutics stock worth more than $4,035,551 as of December 5th. This net worth approximation does not reflect any other assets that Ms. Yen may own. Additionally, Ms. Yen receives an annual salary of $317,190.00 as Senior Vice President, Clinical Operations at Soleno Therapeutics. Learn More about Kristen Yen's net worth.

How old is Kristen Yen?

Ms. Yen is currently 55 years old. There are 5 older executives and no younger executives at Soleno Therapeutics. The oldest executive at Soleno Therapeutics is Mr. James H. MacKaness, Chief Financial Officer, who is 60 years old. Learn More on Kristen Yen's age.

What is Kristen Yen's salary?

As the Senior Vice President, Clinical Operations of Soleno Therapeutics, Inc., Ms. Yen earns $317,190.00 per year. There are 3 executives that earn more than Ms. Yen. The highest earning executive at Soleno Therapeutics is Dr. Anish Bhatnagar M.D., President, CEO, COO & Director, who commands a salary of $1,060,000.00 per year. Learn More on Kristen Yen's salary.

How do I contact Kristen Yen?

The corporate mailing address for Ms. Yen and other Soleno Therapeutics executives is 203 REDWOOD SHORES PARKWAY SUITE 500, REDWOOD CITY CA, 94065. Soleno Therapeutics can also be reached via phone at (650) 213-8444 and via email at [email protected]. Learn More on Kristen Yen's contact information.

Has Kristen Yen been buying or selling shares of Soleno Therapeutics?

Kristen Yen has not been actively trading shares of Soleno Therapeutics during the past quarter. Most recently, Kristen Yen sold 2,340 shares of the business's stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $46.18, for a transaction totalling $108,061.20. Following the completion of the sale, the insider now directly owns 76,605 shares of the company's stock, valued at $3,537,618.90. Learn More on Kristen Yen's trading history.

Who are Soleno Therapeutics' active insiders?

Soleno Therapeutics' insider roster includes Anish Bhatnagar (CEO), Patricia Hirano (Insider), Michael Huang (VP), James Mackaness (CFO), Matthew Pauls (Director), Jack Schuler (Major Shareholder), and Kristen Yen (Senior Vice President, Clinical Operations). Learn More on Soleno Therapeutics' active insiders.

Are insiders buying or selling shares of Soleno Therapeutics?

In the last twelve months, insiders at the sold shares 11 times. They sold a total of 964,128 shares worth more than $65,188,281.94. The most recent insider tranaction occured on July, 1st when insider Patricia C Hirano sold 3,830 shares worth more than $316,970.80. Insiders at Soleno Therapeutics own 6.4% of the company. Learn More about insider trades at Soleno Therapeutics.

Information on this page was last updated on 7/1/2025.

Kristen Yen Insider Trading History at Soleno Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2025Sell2,340$46.18$108,061.2076,605View SEC Filing Icon  
10/1/2024Sell3,108$49.43$153,628.4481,465View SEC Filing Icon  
8/28/2024Sell5,270$47.58$250,746.6090,008View SEC Filing Icon  
8/5/2024Sell5,017$45.77$229,628.09101,235View SEC Filing Icon  
7/1/2024Sell2,170$41.54$90,141.8021,252View SEC Filing Icon  
4/1/2024Sell2,218$41.34$91,692.1223,422View SEC Filing Icon  
1/25/2024Sell397$48.30$19,175.1025,640View SEC Filing Icon  
12/13/2023Sell17,916$37.76$676,508.162,037View SEC Filing Icon  
11/29/2023Sell3,979$27.83$110,735.5725,913View SEC Filing Icon  
See Full Table

Kristen Yen Buying and Selling Activity at Soleno Therapeutics

This chart shows Kristen Yen's buying and selling at Soleno Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Soleno Therapeutics Company Overview

Soleno Therapeutics logo
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Read More

Today's Range

Now: $52.68
Low: $49.98
High: $53.10

50 Day Range

MA: $57.51
Low: $43.54
High: $69.95

2 Week Range

Now: $52.68
Low: $41.50
High: $90.32

Volume

1,112,229 shs

Average Volume

1,938,494 shs

Market Capitalization

$2.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A